Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Common viruses associated with lower pediatric multiple sclerosis risk.

Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, Oksenberg JR, James JA; US Pediatric MS Network.

Neurology. 2011 Jun 7;76(23):1989-95. doi: 10.1212/WNL.0b013e31821e552a.

2.

Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.

Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, James JA.

Mult Scler. 2013 Jun;19(7):891-5. doi: 10.1177/1352458512469693. Epub 2012 Dec 11.

3.

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.

Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, McGowan M, O'Mahony J, Magalhaes S, Hanwell H, Vieth R, Tellier R, Vincent T, Disanto G, Ebers G, Wambera K, Connolly MB, Yager J, Mah JK, Booth F, Sebire G, Callen D, Meaney B, Dilenge ME, Lortie A, Pohl D, Doja A, Venketaswaran S, Levin S, Macdonald EA, Meek D, Wood E, Lowry N, Buckley D, Yim C, Awuku M, Cooper P, Grand'maison F, Baird JB, Bhan V, Marrie RA.

Lancet Neurol. 2011 May;10(5):436-45. doi: 10.1016/S1474-4422(11)70045-X. Epub 2011 Mar 31.

PMID:
21459044
4.

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.

De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A.

Neurology. 2008 Mar 25;70(13 Pt 2):1113-8. doi: 10.1212/01.wnl.0000294325.63006.f8. Epub 2008 Feb 13.

PMID:
18272866
5.

A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.

Xiao D, Ye X, Zhang N, Ou M, Guo C, Zhang B, Liu Y, Wang M, Yang G, Jing C.

Sci Rep. 2015 Dec 11;5:18083. doi: 10.1038/srep18083.

6.

HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.

Disanto G, Magalhaes S, Handel AE, Morrison KM, Sadovnick AD, Ebers GC, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2011 Mar 1;76(9):781-6. doi: 10.1212/WNL.0b013e31820ee1cd. Epub 2011 Feb 2.

7.

Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.

Makhani N, Banwell B, Tellier R, Yea C, McGovern S, O'Mahony J, Ahorro JM, Arnold D, Sadovnick AD, Marrie RA, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

Mult Scler. 2016 Mar;22(3):385-8. doi: 10.1177/1352458515595876. Epub 2015 Jul 21.

PMID:
26199356
8.

Association of Epstein-Barr virus infection with multiple sclerosis in India.

Pandit L, Malli C, D'Cunha A, Shetty R, Singhal B.

J Neurol Sci. 2013 Feb 15;325(1-2):86-9. doi: 10.1016/j.jns.2012.12.004. Epub 2013 Jan 9.

PMID:
23312038
9.

Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.

Langer-Gould A, Wu J, Lucas R, Smith J, Gonzales E, Amezcua L, Haraszti S, Chen LH, Quach H, James JA, Barcellos LF, Xiang AH.

Neurology. 2017 Sep 26;89(13):1330-1337. doi: 10.1212/WNL.0000000000004412. Epub 2017 Aug 30.

PMID:
28855411
10.
11.

Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.

Nielsen TR, Rostgaard K, Askling J, Steffensen R, Oturai A, Jersild C, Koch-Henriksen N, Sørensen PS, Hjalgrim H.

Mult Scler. 2009 Apr;15(4):431-6. doi: 10.1177/1352458508100037. Epub 2009 Jan 19.

PMID:
19153174
12.

Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.

Al-Temaimi R, Alroughani R, Jacob S, Al-Mulla F.

J Neuroimmunol. 2015 Aug 15;285:57-61. doi: 10.1016/j.jneuroim.2015.05.021. Epub 2015 May 21.

PMID:
26198919
13.

Epstein-Barr virus in pediatric multiple sclerosis.

Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B.

JAMA. 2004 Apr 21;291(15):1875-9.

PMID:
15100207
14.

Determinants of Ethnic Differences in Cytomegalovirus, Epstein-Barr Virus, and Herpes Simplex Virus Type 1 Seroprevalence in Childhood.

Jansen MA, van den Heuvel D, Bouthoorn SH, Jaddoe VW, Hooijkaas H, Raat H, Fraaij PL, van Zelm MC, Moll HA.

J Pediatr. 2016 Mar;170:126-34.e1-6. doi: 10.1016/j.jpeds.2015.11.014. Epub 2015 Dec 17.

PMID:
26707579
15.

The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.

Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI, Marta M, Freijo M, Costa PP, Mendonça D, Monteiro L, Armas JB, Martins B.

J Neurol Sci. 2007 Jul 15;258(1-2):69-74. Epub 2007 Apr 6.

PMID:
17412364
16.

HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.

Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Torrabadella M, Azqueta C, Arbizu T.

Eur J Neurol. 2011 Feb;18(2):337-42. doi: 10.1111/j.1468-1331.2010.03148.x.

PMID:
20629714
17.

Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.

James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, Harley JB.

Arthritis Rheum. 2001 May;44(5):1122-6.

18.

The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.

Tuwir I, Dunne C, Crowley J, Saddik T, Murphy R, Cassidy L.

Br J Ophthalmol. 2007 Oct;91(10):1288-92.

19.

Epstein-Barr virus and multiple sclerosis: interaction with HLA.

Sundqvist E, Sundström P, Lindén M, Hedström AK, Aloisi F, Hillert J, Kockum I, Alfredsson L, Olsson T.

Genes Immun. 2012 Jan;13(1):14-20. doi: 10.1038/gene.2011.42. Epub 2011 Jul 21.

PMID:
21776012
20.

Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.

Strautins K, Tschochner M, James I, Choo L, Dunn DS, Pedrini M, Kermode A, Carroll W, Nolan D.

Mult Scler. 2014 Mar;20(3):286-94. doi: 10.1177/1352458513498829. Epub 2013 Jul 25.

PMID:
23886832

Supplemental Content

Support Center